FDA advisers vote against sleep peptide as they debate safety and health claims


The FDA’s advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *